We provide our proprietary diagnostic approach, including our unique contrast agent, Combidex, to save the lives of hundreds of cancer patients annually. We educate as many healthcare professionals as possible worldwide to enable them to improve their diagnostic methods and reach a much more accurate and reliable diagnostics of their patients.
Alveron Pharma
Alveron Pharma is developing a unique coagulation platform technology with the world’s first cyclodextrin-based anticoagulant reversal drug.